ALLERGY THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.875 GBX | 0.00% |
|
+0.88% | +15.00% |
| 04-03 | Allergy Therapeutics Announces Resignation of Mary Tavener as Non-Executive Director | CI |
| 03-27 | EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line | AN |
Quotes 5-day view
Delayed Quote London S.E.| 2024-04-30 | 2024-05-01 | 2024-05-02 | Today | 2024-05-03 | |
|---|---|---|---|---|---|
| Last | 2.9 p | 2.875 p | 2.875 p | 2.875 p | 2.875 p |
| Volume | 782 547 | 759 943 | 973 172 | 320 409 | 315 076 |
| Change | 0.00% | -0.86% | 0.00% | 0.00% | 0.00% |
| Opening | 2.90 | 2.95 | 2.88 | 2.88 | 2.875 |
| High | 3.00 | 3.00 | 3.00 | 3.00 | 3 |
| Low | 2.80 | 2.74 | 2.88 | 2.75 | 2.99 |
Performance
| 1 week | +0.88% | ||
| Current month | -0.86% | ||
| 1 month | -4.17% | ||
| 3 months | +22.34% | ||
| 6 months | +98.28% | ||
| Current year | +15.00% | ||
| 1 year | -54.00% | ||
| 3 years | -86.69% | ||
| 5 years | -68.92% | ||
| 10 years | -84.25% |
Volumes
marketsDaily volume
315 076
Estimated daily volume
315 076
Avg. Volume 20 sessions
720 106
Daily volume ratio
0.44
Avg. Volume 20 sessions GBX
2 070 304.75
Avg. Volume 20 sessions USD
2 070 304.75
Record volume 1
198 583 900
Record volume 2
50 221 640
Record volume 3
43 582 940
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (GBX)
136 449 517
Capitalization (USD)
171 231 863
Net sales (GBP)
59 587 000
Net sales (USD)
74 776 322
Free-Float
6.79 %
Free-Float capitalization (GBX)
9 259 255
Free-Float capitalization (USD)
11 619 532
Average Daily Capital Traded
1.52%
Highs and lows
1 week
2.74
3.00
1 month
2.653.10
Current year
1.803.20
1 year
0.803.90
3 years
0.8040.50
5 years
0.8040.50
10 years
0.8040.50
Indicators
Moving average 5 days
2.88
Moving average 20 days
2.85
Moving average 50 days
2.72
Moving average 100 days
2.57
Price spread / (MMA5)
+0.17%
Price spread / (MMA20)
-1.00%
Price spread / (MMA50)
-5.30%
Price spread / (MMA100)
-10.66%
STIM
RSI 9 days
55.23
RSI 14 days
55.95
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | +0.88% | +15.00% | -54.00% | 171M | ||
| +0.18% | +0.86% | -1.47% | +15.74% | 103B | ||
| +2.14% | +8.43% | +9.04% | +19.24% | 101B | ||
| -1.24% | +2.66% | +4.40% | +1.01% | 23.07B | ||
| +0.49% | +6.28% | -12.18% | -15.83% | 22.23B | ||
| +5.91% | +5.45% | -4.36% | -25.41% | 18.05B | ||
| -2.02% | +4.98% | -39.98% | -35.33% | 17.18B | ||
| -0.06% | +5.42% | -10.23% | -38.90% | 16.94B | ||
| +0.67% | +3.51% | +6.84% | +42.74% | 14.07B | ||
| +2.36% | +3.84% | +38.66% | +6.60% | 12.35B | ||
| -1.13% | +0.24% | -24.53% | -31.53% | 8.36B | ||
| +1.57% | +3.55% | +313.49% | +258.74% | 8.35B | ||
| -2.83% | +0.89% | +8.86% | +49.75% | 8.06B | ||
| -4.12% | +9.58% | -52.84% | -69.98% | 7.75B | ||
| -0.12% | +0.16% | +0.33% | +33.27% | 7.73B | ||
| +2.20% | +8.65% | +5.05% | +33.30% | 7.02B | ||
| Average | +0.21% | +4.76% | +16.00% | +11.84% | ||
| Weighted average by Cap. | +0.76% | +3.90% | +6.23% | +11.82% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
5050f306.pxUloCd9y8PLRcUTW7OScGnkv0Ec1DBA4zQFdD8REtg.0HpPzFZOupL4NKRbLOvFOkSrjgpXmEQXsA1PA3VLZbv9eG_0TTqgq-Ygpg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 09:48:46 | 2.99 | 6,535 | 315,076 |
| 09:00:20 | 3 | 1,890 | 308,541 |
| 08:18:48 | 3 | 150,000 | 306,651 |
| 06:00:01 | 3 | 56,651 | 156,651 |
Monthly variations
Annual change
| 2024 | +15.00% | ||
| 2023 | -60.00% | ||
| 2022 | -80.62% | ||
| 2021 | +93.98% | ||
| 2020 | +62.20% | ||
| 2019 | -24.77% | ||
| 2018 | -52.19% | ||
| 2017 | +36.53% | ||
| 2016 | -29.24% | ||
| 2015 | +20.41% | ||
| 2014 | +206.25% | ||
| 2013 | -29.67% | ||
| 2012 | +10.98% | ||
| 2011 | +26.15% | ||
| 2010 | -44.92% | ||
| 2009 | +40.48% | ||
| 2008 | -74.07% | ||
| 2007 | -58.88% | ||
| 2006 | +28.76% | ||
| 2005 | -17.74% | ||
| 2004 | +24.83% |
- Stock Market
- Equities
- AGY Stock
- Quotes Allergy Therapeutics plc
